期刊文献+

颈动脉内中膜增厚及斑块形成相关危险因素分析 被引量:1

The association analysis of risk factors in carotid intima-media thickness(IMT) and plaque formation
下载PDF
导出
摘要 目的探讨影响颈动脉内中膜增厚及斑块形成患者尤其伴有2型糖尿病者的相关危险因素。方法对405例住院患者进行颈动脉彩色多普勒超声检测,根据颈动脉IMT将其分为3组:A组:IMT正常组(IMT<0.9mm)、B组:IMT增厚组(1.0mm-1.2mm)、C组:颈动脉硬化斑块形成组(IMT>1.2mm或者有斑块形成),比较三组人群临床特点差异,并对其中129例伴有2糖尿病患者IMT增厚及斑块形成相关危险因素进行logistic回归分析。结果 C组高血压和糖尿病患病率明显高于A组,同时SBP,BMI,FBG和TG水平亦明显增高于A组。Logistic回归分析显示2型糖尿病患者FBG(95%CI:1.03-1.98,OR=1.23,P=0.04)和尿酸水平(95%CI:1.01-2.68,OR=1.57,P=0.02)与颈动脉IMT增厚及斑块形成明显相关。结论颈动脉IMT增厚及斑块形成者心脑血管高危因素患病率明显高于IMT正常组。FBG和尿酸水平是2型糖尿病患者颈动脉硬化及颈动脉IMT增厚的危险因素。 Objective To study the influence factors of carotid intima-media thickness and plaques, especially in patients with type 2 diabetes patients.Methods 405 inpatients were enrolled and carotid artery Doppler ultrasound was detected. Samples were divided into 3 groups: group A: normal IMT group (IMT〈0.9mm) , group B: IMT thickness group (1.0mm to 1.2mm) and group C: carotid thickness or plaque formation group (IMT〉1.2mm or plaque formation) . Clinical characteristics were analyses and multivariate logistic regression analysis assessed the association the predictors for thickening of IMT and plaque formation in 129 type 2 diabetes patients.Results The prevalence of hypertension, diabetes in group C were significantly higher than group A.SBP, BMI, FBG and TG levels were also obviously higher in group C. Logistic regression analysis showed that FBG (OR=1.23,P=-0.04) and uric acid levels (OR=1.57,P=0.02) were overtly related to thickening and plaque formation in patients with type 2 diabetes.Conclusion Prevalence of cardiovascular risk factors in patients with carotid IMT thickness or plaque was more popular than IMT normal group. Age, diabetes duration and uric acid levels are risk factors for carotid IMT thickening and plaques in type 2 diabetes patients.
出处 《云南医药》 CAS 2014年第5期517-519,共3页 Medicine and Pharmacy of Yunnan
基金 云南省教育厅科学研究基金一般项目(2011Y181)
关键词 IMT 颈动脉彩色多普勒 危险因素分析 Doppler ultrasound Risk factors
  • 相关文献

参考文献7

二级参考文献15

  • 1Mellen PB, Bleyer A J, Elinger TP, et al. Serum uric acid predicts in- cident hypertension in a biethnic cohort: the atherosclerosis risk in com- munities study F.I3. HvDertension. 2006. 48 (6), 1037-1042. 被引量:1
  • 2Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk [J]. NEngJMed, 9008, 359: 1811-1821. 被引量:1
  • 3Parikh A, Daneman D. Is carotid ultrasound a useful tool in assessing cardiovascular disease in individuals with diabetes? [ J]. Diabetes Technol Ther, 2004, 6 ( 1 ) : 65 - 69. 被引量:1
  • 4Fang J, Alaerman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow- up study, 1971 -1992. National Health and Nutrtion Examination Survey [ J ]. JAMA, 2000, 283 (18) : 2404 -241. 被引量:1
  • 5Holme I, Aastveit AH, Hammar N, et al. Uric acid and risk of myo- cardial infarction, stroke and congestive heart failure in 417, 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) [J]. J Intern ned, 2009, 266 (6): 558-570. 被引量:1
  • 6Tseng CH. Independent association of uric acid levels with peripheral ar- terial disease in Taiwan Residents patients with type 2 diabetes [ J ]. Diabet Med, 2004, 21 (7): 724-729. 被引量:1
  • 7Saijo Y, Utsugi M, Yoshioka E, et al. Relationships of C - reactive protein, uric acid, and glomerular filtration rate to arterial stiffness in Japanese subjects [J]. J Hum Hypertens, 2005, 19 (11) : 907 - 913. 被引量:1
  • 8Coutinho TA, Turner ST, Peyser PA, et al. Associations of serum uric acid with mrkers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis [J]. Am J Hytertension, 2007, 20 (1): 83 - 89. 被引量:1
  • 9Rodolfo Le?o Borges,Artur Beltrame Ribeiro,Maria Teresa Zanella,Marcelo Costa Batista.Uric Acid as a Factor in the Metabolic Syndrome[J].Current Hypertension Reports.2010(2) 被引量:1
  • 10N Lawrence Edwards.The role of hyperuricemia in vascular disorders[J].Current Opinion in Rheumatology.2009(2) 被引量:1

共引文献40

同被引文献21

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部